Back to Search Start Over

Modified balloons to prepare severely calcified coronary lesions before stent implantation: a systematic review and meta-analysis of randomized trials.

Authors :
Scalamogna, Maria
Kuna, Constantin
Voll, Felix
Aytekin, Alp
Lahu, Shqipdona
Kessler, Thorsten
Kufner, Sebastian
Rheude, Tobias
Sager, Hendrik B.
Xhepa, Erion
Wiebe, Jens
Joner, Michael
Ndrepepa, Gjin
Kastrati, Adnan
Cassese, Salvatore
Source :
Clinical Research in Cardiology; Jul2024, Vol. 113 Issue 7, p995-1005, 11p
Publication Year :
2024

Abstract

Background: The performance of modified balloons (namely cutting or scoring balloons) to prepare severely calcified lesions in patients undergoing percutaneous coronary intervention (PCI) remains controversial. We investigated the clinical and imaging outcomes of patients undergoing PCI assigned to modified balloon therapy to prepare severely calcified coronary lesions before stent implantation. Methods: In this meta-analysis, we aggregated the study-level data from trials enrolling invasively treated patients who were randomly assigned to modified balloon or control therapy to prepare severely calcified lesions before stenting. The primary outcome was major adverse cardiac events (MACE), including death, myocardial infarction (MI), and repeat revascularization. The secondary outcomes included the individual components of the primary outcome, coronary perforation and final minimal stent area (MSA) as measured by intracoronary imaging. Results: A total of 648 participants in six trials were allocated to modified balloon therapy (n = 335) or control therapy (semi-compliant, non-compliant, or super high-pressure balloon, n = 313). The median follow-up was 11 months. Overall, MACE occurred in 8.96% of patients assigned to a modified balloon and 12.78% of patients assigned to control therapy [risk ratio = 0.70, 95% confidence interval (CI) 0.35–1.39; P = 0.24]. There was a significant treatment effect-by-modified balloon type interaction for the outcome MACE in patients assigned to cutting balloon compared with control therapy [RR = 0.40 (0.28–0.56), P for interaction (P<subscript>int</subscript>) < 0.001]. Patients treated with a modified balloon compared with control therapy showed neither a significant difference for the other clinical outcomes nor for final MSA [standardized mean difference = 0.67 (− 0.71, 2.06); P = 0.26]. Conclusions: In patients treated with PCI for severely calcific coronary artery disease a strategy of lesion preparation with a modified balloon before stenting does not improve clinical or imaging outcomes compared with control therapy. The different performance of cutting and scoring balloons warrants further investigation. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
18610684
Volume :
113
Issue :
7
Database :
Complementary Index
Journal :
Clinical Research in Cardiology
Publication Type :
Academic Journal
Accession number :
178232169
Full Text :
https://doi.org/10.1007/s00392-023-02324-y